1. Home
  2. VAI vs NSRX Comparison

VAI vs NSRX Comparison

Compare VAI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VAI

Valor Energy Incorporated Common Stock

N/A

Current Price

$1.66

Market Cap

31.0M

Sector

N/A

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

SELL

Current Price

$2.87

Market Cap

37.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VAI
NSRX
Founded
2014
2019
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
37.1M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
VAI
NSRX
Price
$1.66
$2.87
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $16.50
AVG Volume (30 Days)
★ 58.5K
15.0K
Earning Date
11-18-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,546,127.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.56
$1.98
52 Week High
$2.91
$9.50

Technical Indicators

Market Signals
Indicator
VAI
NSRX
Relative Strength Index (RSI) 39.75 35.77
Support Level N/A $2.04
Resistance Level $2.34 $3.61
Average True Range (ATR) 0.30 0.30
MACD -0.09 -0.02
Stochastic Oscillator 13.48 1.39

Price Performance

Historical Comparison
VAI
NSRX

About VAI Valor Energy Incorporated Common Stock

Valor Energy Inc, formerly Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with a lease term of no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: